Treatment
Patients will receive clinical trials
We’re tracking 291 recruiting studies that include Patients will receive, each written for real people, not researchers, below.
Recruiting studies
- NCT06986694Recruiting
Voodoo flossing for knee arthritis pain and mobility
This study tests if a special flossing technique (tight elastic bands wrapped around the knee) can improve pain, stiffness, and walking in people with knee osteoarthritis. It is designed for patients who have had knee pain for at least 3 months and have trouble walking or balancing.
Lahore, Punjab ProvinceAges 45–65 - NCT06855082Recruiting
Stoma self-care app study for colostomy patients
This trial tests if a smartphone app can help people with a new colostomy learn to care for their stoma at home. It is designed for patients who are alert, can speak Mandarin or Minnan, and have a smartphone.
TaipeiAges 20 years+ - NCT05874401RecruitingPhase 4
Trilaciclib added to topotecan for advanced small cell lung cancer
This study tests whether adding trilaciclib (a medicine given with chemotherapy) can improve outcomes for people with extensive-stage small cell lung cancer who are being treated with topotecan. It compares trilaciclib versus a placebo (inactive pill) while you receive topotecan.
SevilleAges 18 years+ - NCT05993234Recruiting
Trastuzumab deruxtecan for advanced HER2-positive stomach cancer
This study looks at a treatment called T-DXd (trastuzumab deruxtecan) for people with advanced stomach or gastroesophageal junction cancer that is HER2-positive and has been previously treated with trastuzumab. It also follows people receiving standard therapies to compare results.
KlagenfurtAges 18 years+ - NCT06965803Recruiting
Does continuous glucose monitoring improve quality of life for people with diabetes?
This study tests if using a continuous glucose monitor (CGM) along with standard diabetes education helps people with diabetes feel more satisfied and have a better quality of life. You will be asked to wear a CGM device and complete surveys about your experience.
Los Angeles, CaliforniaAges 18 years+ - NCT07492641RecruitingPhase 3
A new drug plus letrozole for advanced HR+ breast cancer
This trial tests a new medicine (BGB-43395) combined with letrozole against the usual CDK4/6 inhibitor plus letrozole. It is for people with advanced or metastatic HR-positive, HER2-negative breast cancer who have not yet had treatment for advanced disease.
Birmingham, AlabamaAges 18 years+ - NCT06891144Recruiting
Study of older adults with AML getting intensive treatment
This study follows people aged 60 and older with newly diagnosed acute myeloid leukemia (AML) who are receiving strong chemotherapy. It aims to learn more about their health outcomes and better understand the disease in this age group.
AngersAges 60 years+ - NCT06933472RecruitingPhase 3
Study of a new phosphate binder for dialysis patients
This trial tests a new drug called AP301 to lower high phosphate levels in people on dialysis. It's designed to help control phosphate, which can be hard to manage with diet and current medications.
Granada Hills, CaliforniaAges 12 years+ - NCT07373366RecruitingPhase 2
Noninvasive brain stimulation for TBI patients and healthy volunteers
This trial tests whether a noninvasive brain stimulation technique can help people who have suffered a traumatic brain injury (TBI), specifically those with diffuse axonal injury (DAI). It also includes healthy volunteers for comparison.
São Paulo, São PauloAges Any age - NCT06949319Recruiting
Stroke Risk and Blood Clots in New Atrial Fibrillation
This study looks at stroke risk and blood clotting in people who have just been diagnosed with atrial fibrillation (AFib) that is not caused by a heart valve problem, and who have not yet taken blood thinners. It aims to better understand how blood clots form in this condition.
Esbjerg, Region SyddanmarkAges 18 years+ - NCT06905925Recruiting
Training program for people with a permanent colostomy
This trial tests whether a training program can help people who have a permanent colostomy feel more confident in managing their daily care. If you are scheduled for a permanent colostomy, can speak Turkish, and have a phone, this study may be a good fit.
Adana, YüreğirAges 18–100 - NCT06931717RecruitingPhase 3
Immunotherapy after lung cancer surgery for those not getting chemo
This trial tests if the drug cemiplimab can prevent non-small cell lung cancer from coming back after surgery. It's for people whose tumors have PD-L1 levels of at least 1% and who are not receiving standard chemotherapy after surgery.
ViennaAges 18 years+ - NCT07054450Enrolling by invitation
Assessment and rehabilitation for chronic pinched nerve in the neck
This trial tests a program of assessment and rehabilitation (including physical exercise and possibly a nutraceutical supplement) for people with chronic cervical radiculopathy — a pinched nerve in the neck causing pain, numbness, or weakness in the arm. It may help reduce pain and improve function without surgery.
CraiovaAges 50–79 - NCT06797297RecruitingPhase 2
Study of IBI363 vs pembrolizumab for advanced mucosal or acral melanoma
This trial tests a new drug, IBI363, compared to the standard drug pembrolizumab (Keytruda) for people with advanced mucosal or acral melanoma who have not had treatment before. It aims to see if IBI363 works better or as well as the usual treatment.
Hefei, AnhuiAges 18 years+ - NCT07042438RecruitingPhase 2
Fecal transplant to improve CAR T therapy for lymphoma
This study tests whether a fecal transplant (transferring healthy gut bacteria) can improve outcomes for people with certain lymphomas who have taken strong antibiotics and are about to get CAR T-cell therapy (Yescarta). The goal is to see if rebuilding gut bacteria helps the treatment work better.
Duarte, CaliforniaAges 18 years+ - NCT06908473Enrolling by invitationPhase 3
Tongmai Jiangtang capsule for heart risks in metabolic syndrome
This trial tests whether the Tongmai Jiangtang capsule can reduce serious heart and stroke problems in older adults with metabolic syndrome who are also at high risk for heart disease. It focuses on people with a specific traditional Chinese medicine pattern called Qi-deficiency and Blood Stasis.
Guangzhou, GuangdongAges 65 years+ - NCT06899906Recruiting
Dalbavancin as long-term infection control: a safety study
This study looks back at patients who received the antibiotic dalbavancin as a long-term suppressive therapy for stubborn infections. It aims to see how well it worked and if it was safe.
France, LyonAges Any age - NCT07518147RecruitingPhase 3
BL-M05D1 for advanced stomach cancer after first treatment
This study tests a new antibody drug (BL-M05D1) for advanced stomach or lower esophagus cancer that did not respond to first-line chemotherapy. The drug targets a protein called claudin 18.2 found on some cancer cells and may help slow or shrink the cancer.
Beijing, Beijing MunicipalityAges 18–75 - NCT06346119Recruiting
Touch relaxation in ICU patients on a breathing machine
This study tests whether gentle touch therapy (like a hand or foot massage) helps reduce stress in patients who are on a breathing machine and sedated in the ICU. The goal is to make the recovery process more comfortable.
NiortAges 18 years+ - NCT07239310Recruiting
Device to improve memory and thinking in early Alzheimer's
This study tests a device called Neuclare that aims to temporarily boost memory and thinking skills in people with mild cognitive impairment or very early Alzheimer's disease. It could offer a non-drug way to help with daily mental tasks.
Cheonan, Chungcheongnam-doAges 55–90 - NCT07207278Recruiting
Genetics and immune study of lung signet ring cell cancer
This research study is looking at the unique genetic makeup and immune features of a rare type of lung cancer called signet ring cell carcinoma. By studying tumor samples and medical data, researchers hope to find better ways to understand and eventually treat this cancer.
Hangzhou, ZhejiangAges 18–85 - NCT07509450Recruiting
Fecal transplant study for CAR-T and stem cell transplant patients
This pilot study tests whether giving a fecal microbiota transplant before standard CAR-T therapy (for B-cell lymphoma) or reduced-intensity stem cell transplant (for AML or high-risk MDS) can improve treatment outcomes. It aims to see if restoring gut bacteria helps reduce complications.
Toronto, OntarioAges 18 years+ - NCT05997056RecruitingPhase 2
Nab-sirolimus for neuroendocrine tumors of gut, lung, or pancreas
This trial tests a new drug, nab-sirolimus, for people with certain types of neuroendocrine tumors that have spread or can't be removed by surgery. It's for those who haven't tried a similar treatment before.
Newport Beach, CaliforniaAges 18 years+ - NCT06676696RecruitingPhase 4
Stopping immunosuppression after failed kidney transplant
This study compares what happens when patients with a failed kidney transplant (still in the body) stop their immunosuppressant medicines at 6 months versus continuing them. The goal is to safely prevent your immune system from becoming too sensitive, which can make finding a new donor kidney harder.
BarcelonaAges 18 years+
Common questions
- Are there clinical trials studying Patients will receive?
- Yes. Clin2 currently lists 291 recruiting studies that include Patients will receive, drawn from the U.S. registry and rewritten for real people so you can see what each is testing and who it's for.
- How do I know if I qualify for a Patients will receive trial?
- Each study lists its own eligibility criteria — rules about condition, age, and prior treatments. On every Clin2 trial page we explain these in plain language and offer a short, optional pre-screen for a fit read. The study team makes the final decision.
- Is Patients will receive an approved treatment?
- A drug being studied in a trial may be investigational (still being tested) or already approved and being studied for a new use. Each study page explains what phase it's in. Clin2 does not provide medical advice — talk with your doctor about whether Patients will receive or a specific trial is right for you.
Related treatments
Clin2 helps you find and understand clinical trials and does not provide medical advice. Study data comes from ClinicalTrials.gov. A drug appearing here is being studied in a trial and may be investigational. Talk with your doctor about whether a specific treatment or trial is right for you.